[go: up one dir, main page]

HK1013289A1 - Naphthalene derivatives as prostaglandin 12 agonists - Google Patents

Naphthalene derivatives as prostaglandin 12 agonists Download PDF

Info

Publication number
HK1013289A1
HK1013289A1 HK98114588A HK98114588A HK1013289A1 HK 1013289 A1 HK1013289 A1 HK 1013289A1 HK 98114588 A HK98114588 A HK 98114588A HK 98114588 A HK98114588 A HK 98114588A HK 1013289 A1 HK1013289 A1 HK 1013289A1
Authority
HK
Hong Kong
Prior art keywords
compound
salt
hydroxy
formula
naphthyl
Prior art date
Application number
HK98114588A
Other languages
German (de)
English (en)
French (fr)
Chinese (zh)
Other versions
HK1013289B (en
Inventor
Taniguchi Kiyoshi
Nagano Masanobu
Hattori Kouji
Tsubaki Kazunori
Okitsu Osamu
Tabuchi Seiichiro
Original Assignee
Fujisawa Pharmaceutical Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB9404734A external-priority patent/GB9404734D0/en
Priority claimed from GB9407036A external-priority patent/GB9407036D0/en
Application filed by Fujisawa Pharmaceutical Co., Ltd. filed Critical Fujisawa Pharmaceutical Co., Ltd.
Publication of HK1013289A1 publication Critical patent/HK1013289A1/en
Publication of HK1013289B publication Critical patent/HK1013289B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • C07D213/64One oxygen atom attached in position 2 or 6
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06Esters of carbamic acids
    • C07C271/08Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/12Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06Esters of carbamic acids
    • C07C271/08Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/26Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring
    • C07C271/28Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring to a carbon atom of a non-condensed six-membered aromatic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C281/00Derivatives of carbonic acid containing functional groups covered by groups C07C269/00 - C07C279/00 in which at least one nitrogen atom of these functional groups is further bound to another nitrogen atom not being part of a nitro or nitroso group
    • C07C281/02Compounds containing any of the groups, e.g. carbazates
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/14Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/12Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/16Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by esterified hydroxyl radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00Systems containing two condensed rings
    • C07C2602/02Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Epoxy Compounds (AREA)
  • Pyridine Compounds (AREA)
HK98114588.2A 1994-03-10 1995-03-08 Naphthalene derivatives as prostaglandin 12 agonists HK1013289B (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB9404734A GB9404734D0 (en) 1994-03-10 1994-03-10 Heterocyclic compounds
GB9404734.7 1994-03-10
GB9407036A GB9407036D0 (en) 1994-04-08 1994-04-08 Naphthalene derivatives
GB9407036.4 1994-04-08
PCT/JP1995/000373 WO1995024393A1 (en) 1994-03-10 1995-03-08 Naphthalene derivatives as prostaglandin i2 agonists

Publications (2)

Publication Number Publication Date
HK1013289A1 true HK1013289A1 (en) 1999-08-20
HK1013289B HK1013289B (en) 2002-01-18

Family

ID=

Also Published As

Publication number Publication date
TW282456B (xx) 1996-08-01
JP3245864B2 (ja) 2002-01-15
GR3037080T3 (en) 2002-01-31
RU2155188C2 (ru) 2000-08-27
PT749424E (pt) 2002-03-28
CN1057522C (zh) 2000-10-18
HUT75226A (en) 1997-04-28
US5863918A (en) 1999-01-26
EP0749424A1 (en) 1996-12-27
HU224822B1 (en) 2006-02-28
ATE205479T1 (de) 2001-09-15
US5763489A (en) 1998-06-09
WO1995024393A1 (en) 1995-09-14
KR970701698A (ko) 1997-04-12
CA2185104A1 (en) 1995-09-14
DE69522676D1 (de) 2001-10-18
CN1147250A (zh) 1997-04-09
JPH09509958A (ja) 1997-10-07
EP0749424B1 (en) 2001-09-12
DE69522676T2 (de) 2002-04-18
DK0749424T3 (da) 2001-11-26
KR100383305B1 (ko) 2003-11-01
HU9602466D0 (en) 1996-11-28
AU688871B2 (en) 1998-03-19
AU1861895A (en) 1995-09-25
ES2160156T3 (es) 2001-11-01

Similar Documents

Publication Publication Date Title
EP0749424B1 (en) Naphthalene derivatives as prostaglandin i2 agonists
AU686286B2 (en) 4,5-diaryloxazole derivatives
US6300344B1 (en) Heterocyclic compounds
US20050267206A1 (en) Thyroid receptor antagonists for the treatment of cardiac and metabolic disorders
WO2000016760A2 (en) New use of prostaglandin e2 antagonists
TW200811110A (en) Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the β2 adrenergic receptor
WO1994026738A1 (en) N'-heterocyclyl-n-benzofuranyl urea derivatives and their analogs as acat inhibitors
CZ373096A3 (en) Trisubstituted phenyl derivatives, process of their preparation and pharmaceutical compositions containing thereof
HU224823B1 (en) Substituted benzamidines,process for preparing the said compds. and pharmaceutical compns. contg. them
EP0223593A2 (en) Phenoxyalkylcarboxylic acids and esters and their preparation and pharmaceutical formulation
US7902394B2 (en) Calcilytic compounds
JPH10500965A (ja) ヒドロキシルアミン誘導体及びメタロプロテイナーゼ阻害剤としてのその用途
FR2521992A1 (fr) Nouveaux composes de pyridine utiles comme medicaments
EP1042277B1 (en) Naphthalene derivatives
WO1992009561A1 (en) New amide derivatives
WO2000012462A1 (en) Aminoalcohol derivatives and their use as beta 3 adrenergic agonists
HK1013289B (en) Naphthalene derivatives as prostaglandin 12 agonists
WO1994018165A1 (en) Sulfonamide compounds as opioid k-receptor agonists
US6384072B1 (en) Benzocycloheptene derivatives
US4980362A (en) 4-substituted-2-alkoxytetrahydrofuran derivatives
EP0718307A2 (fr) Dérivés de 1-oxo-2-(phénylsulfonyl-amino)pentylpipéridine, leur préparation et leur application en thérapeutique
WO1994025427A1 (en) Ethanolamine derivatives useful for the treatment of gastrointestinal disorders
JP2003522814A (ja) アミノアルコール誘導体
EP1453796B1 (fr) Propanolaminomethyltetralines, leur preparation et composition pharmaceutiques en contenant

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20060308